Deja-vu all over again… And what happened next? Trade accordingly…
March 11, 2016
On Thursday shares of Sarepta Therapeutics (SRPT) closed up 15% for the day as the company stated that the FDA had set a new FDA independent panel review date. The original review date for Sarepta’s drug Eteplirsen was set to
Bank of America (BAC) is my favorite bank stock right now, and its future looks a lot brighter. The share price could double from here. Bank of America has underperformed for a number of years in an already-shaky banking sector,
Dear Early Investor, Big news in the equity crowdfunding world this week. Virtual reality startup Virtuix has announced that it will be open to the public for investment on March 23. The company plans to raise between $10 million and $15 million. This
Yesterday’s market indecision (up and down head fakes ending in a flat finish) gave way to an unambiguous conviction. Our benchmark S&P 500 rallied at the open and rose in a couple of waves to its 1.64% closing gain, just
China’s Total Social Financing hugely disappointed in February, as January’s surge was not followed as if renewed economic enthusiasm. The net flow was RMB 780 billion compared to the record RMB 3.42 trillion the month before. This latest update was
On a disappointing new ECB Stimulus package, stocks around the world sold off in true “sell on the facts” fashion, following the ECB announcements. European Central Bank President Mario Draghi and his policy-making compatriots delivered a bigger-than-expected stimulus plan Thursday, but
ETFs are becoming increasingly popular with investors due to their low cost, transparency, easy tradability and tax efficiency. The ETF revolution has made it possible for individual investors to get a convenient, diversified access to almost any investment strategy in
For the first time ever, total credit card debt in the United States is approaching a trillion dollars. Instead of learning painful lessons from the last recession, Americans continue to make the same horrendous financial mistakes over and over again.
I am seeing more and more analysis reporting things like ‘my proprietary indicators have gone positive’ or ‘market risk has now cleared according to my indicators’ and so on and so forth. You’re about a month too late there guys. A market bounce was
